This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ke, S. Articles by Li, C. Search for Related Content PubMed PubMed Citation Articles by Ke, S. Articles by Li, C.

Near-Infrared Optical Imaging of Epidermal Growth Factor Receptor in Breast Cancer Xenografts

¹ Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas,
² Photon Migration Laboratories, Texas A&M University, College Station, Texas

The specificity of a novel epidermal growth factor (EGF)-Cy5.5 fluorescent optical probe in the detection of EGF receptor (EGFr) was assessed using continuous-wave fluorescence imaging accomplished via an intensified charge-coupled device (CCD) camera. Human mammary MDA-MB-468 (EGFr+) and MDA-MB-435 (EGFr-) cancer cells were incubated with Cy5.5, EGF-Cy5.5, or the anti-EGFr monoclonal antibody C225 or EGF followed by EGF-Cy5.5 and examined under a fluorescence microscope. In vivo imaging was performed on mice with s.c. MDA-MB-468 and MDA-MB-435 tumors. Images were obtained every 6 s for 20 min after i.v. injection of each agent and every 24 h after injection for up to 192 h. Additionally, mice with MDA-MB-468 tumors were injected i.v. with C225 24 h before injection of EGF-Cy5.5. EGF-Cy5.5, but not Cy5.5 or indocyanine green dye (ICG), bound to MDA-MB-468 cells. Binding of EGF-Cy5.5 was blocked by C225 and by EGF. In contrast, binding of EGF-Cy5.5 to MDA-MB-435 cells was not observed. Monitoring of the time-fluorescence intensity in mice confirmed that ICG and Cy5.5 had no favorable binding to tumor regardless of EGFr expression level. In contrast, EGF-Cy5.5 accumulated only in MDA-MB-468 tumors. Moreover, tumor uptake of EGF-Cy5.5 was blocked by C225. ICG and Cy5.5 fluorescence was completely absent from the tumor site, regardless of EGFr expression level, 24 h after injection. Little EGF-Cy5.5 fluorescence was detected in MDA-MB-435 tumors 24 h after injection. In MDA-MB-468 tumors, our data suggest that EGF-Cy5.5 may be used as a specific NIR contrast agent for noninvasive imaging of EGFr expression and monitoring of responses to molecularly targeted therapy.

This article has been cited by other articles:

				S. Song, D. Liu, J. Peng, H. Deng, Y. Guo, L. X. Xu, A. D. Miller, and Y. Xu Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo FASEB J, May 1, 2009; 23(5): 1396 - 1404. [Abstract] [Full Text] [PDF]

				J. V. Frangioni New Technologies for Human Cancer Imaging J. Clin. Oncol., August 20, 2008; 26(24): 4012 - 4021. [Abstract] [Full Text] [PDF]

				J. R. Bading and A. F. Shields Imaging of Cell Proliferation: Status and Prospects J. Nucl. Med., June 1, 2008; 49(Suppl_2): 64S - 80S. [Abstract] [Full Text] [PDF]

				D. A. Mankoff, J. M. Link, H. M. Linden, L. Sundararajan, and K. A. Krohn Tumor Receptor Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 149S - 163S. [Abstract] [Full Text] [PDF]

				P. Diagaradjane, J. M. Orenstein-Cardona, N. E. Colon-Casasnovas, A. Deorukhkar, S. Shentu, N. Kuno, D. L. Schwartz, J. G. Gelovani, and S. Krishnan Imaging Epidermal Growth Factor Receptor Expression In vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe Clin. Cancer Res., February 1, 2008; 14(3): 731 - 741. [Abstract] [Full Text] [PDF]

				L. Peng, R. Liu, M. Andrei, W. Xiao, and K. S. Lam In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against {alpha}4{beta}1 integrin Mol. Cancer Ther., February 1, 2008; 7(2): 432 - 437. [Abstract] [Full Text] [PDF]

				B. D. Kulbersh, R. D. Duncan, J. S. Magnuson, J. B. Skipper, K. Zinn, and E. L. Rosenthal Sensitivity and Specificity of Fluorescent Immunoguided Neoplasm Detection in Head and Neck Cancer Xenografts Arch Otolaryngol Head Neck Surg, May 1, 2007; 133(5): 511 - 515. [Abstract] [Full Text] [PDF]

				E. L. Rosenthal, B. D. Kulbersh, T. King, T. R. Chaudhuri, and K. R. Zinn Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts Mol. Cancer Ther., April 1, 2007; 6(4): 1230 - 1238. [Abstract] [Full Text] [PDF]

				J. L. Kovar, M. A. Johnson, W. M. Volcheck, J. Chen, and M. A. Simpson Hyaluronidase Expression Induces Prostate Tumor Metastasis in an Orthotopic Mouse Model Am. J. Pathol., October 1, 2006; 169(4): 1415 - 1426. [Abstract] [Full Text] [PDF]

				K. J. Reichenberger, R. D. Coletta, A. P. Schulte, M. Varella-Garcia, and H. L. Ford Gene Amplification Is a Mechanism of Six1 Overexpression in Breast Cancer Cancer Res., April 1, 2005; 65(7): 2668 - 2675. [Abstract] [Full Text] [PDF]

				X. Chen, P. S. Conti, and R. A. Moats In vivo Near-Infrared Fluorescence Imaging of Integrin {alpha}v{beta}3 in Brain Tumor Xenografts Cancer Res., November 1, 2004; 64(21): 8009 - 8014. [Abstract] [Full Text] [PDF]

				J. Chung, S.-O. Yoon, E. A. Lipscomb, and A. M. Mercurio The Met Receptor and {alpha}6{beta}4 Integrin Can Function Independently to Promote Carcinoma Invasion J. Biol. Chem., July 30, 2004; 279(31): 32287 - 32293. [Abstract] [Full Text] [PDF]